Our contract research organization stands as your trusted partner, offering comprehensive preclinical large and small molecule bioanalysis services to unravel the pharmacokinetic and pharmacodynamic (PK/PD) profiles of your drug candidates and pave the way for successful clinical trials and regulatory approval.
Your Gateway to Comprehensive Bioanalytical Solutions
With a team of seasoned scientists and bioanalysts, we provide a comprehensive suite of preclinical large and small molecule bioanalysis services, tailored to your specific needs. Our expertise encompasses:
- Large Molecule Bioanalysis
- Small Molecule Bioanalysis
- Preclinical PK/PD Studies
- Biomarker Development & Validation
For large molecule bioanalytics we can develop fit for purpose assays, or we can develop and fully validate assays according to client needs. Our main assays are anti-drug antibody screening (ADA) assays and/or antibody titer assays (to test vaccine efficacy). We have many years of experience developing both types of assays using traditional ELISA techniques, and more recently, we have successfully developed both single plex and multiplex assays on the MSD platform.